Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death

NCT02845531 is registered in ClinicalTrials.gov with Kee-joon Choi as lead sponsor.

NCT NCT02845531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02845531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
Lead sponsor
Kee-joon Choi
Phase
Phase 4
Overall status
Recruiting
Start date
November 29, 2016
Completion date
June 30, 2031
Enrollment
140 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, variant, sudden cardiac death